Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.6567
Abstract: Key Points Question Is use of targeted disease-modifying antirheumatic drugs associated with risk of Alzheimer disease and related dementia (ADRD)? Findings In this cohort study including 22 569 propensity score–matched patient pairs, initiation of inhibitors of… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51688
Abstract: The coronavirus disease 2019 (COVID‐19) pandemic has had an unprecedented impact on the healthcare system, economy, and society. Studies have reported that COVID‐19 may cause various neurologic symptoms, including cognitive impairment. We aimed to assess… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5503
Abstract: Tamsulosin has been associated with dementia, but the results have been inconsistent. Concerns have been raised about using exposure assessment time too close to the outcome. We investigated the association between use of α1‐adrenoceptor antagonists… read more here.
Sign Up to like & get recommendations! 3
Published in 2023 at "SLEEP"
DOI: 10.1093/sleep/zsad077.0084
Abstract: Recent evidence suggests that older adults with more frequent and longer daytime naps have an increased risk of Alzheimer’s dementia (AD). We aim to further elucidate whether the timing of daytime napping impacts AD risk.… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Acta Psychiatrica Scandinavica"
DOI: 10.1111/acps.12909
Abstract: To assess the association between benzodiazepine and related drug (BZDR) use and risk of Alzheimer's disease (AD) with cumulative consumption and duration of use based models. read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Journal of neuroendocrinology"
DOI: 10.1111/jne.13235
Abstract: The exact neuropathological mechanism by which the dementia process unfolds is under intense scrutiny. The disease affects about 38 million people worldwide, 70% of which are clinically diagnosed with Alzheimer's disease (AD). If the destruction… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-214494
Abstract: I have read with interest the article by Fardet et al 1 regarding chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer’s disease. This population-based cohort study reported that people who had been… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Neurology"
DOI: 10.1212/wnl.0000000000009816
Abstract: Objective To quantify the impact of a healthy lifestyle on the risk of Alzheimer dementia. Methods Using data from the Chicago Health and Aging Project (CHAP; n = 1,845) and the Rush Memory and Aging… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "PLoS Genetics"
DOI: 10.1371/journal.pgen.1010294
Abstract: For Alzheimer’s disease–a leading cause of dementia and global morbidity–improved identification of presymptomatic high-risk individuals and identification of new circulating biomarkers are key public health needs. Here, we tested the hypothesis that a polygenic predictor… read more here.